Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-19
2006-09-19
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S382000, C514S376000, C548S186000, C548S189000, C548S253000, C548S254000, C548S231000
Reexamination Certificate
active
07109223
ABSTRACT:
This invention relates to potent selective agonists of the EP4subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.
REFERENCES:
Kubodera, et al. Heterocycles (1982), 18, p. 259-63 (STN search report and abstract).
Billot Xavier
Colucci John
Han Yongxin
Wilson Marie-Claire
Young Robert
Ayler Sylvia A.
Camara Valerie J.
Chu Yong
Merck & Co. , Inc.
Saeed Kamal A.
LandOfFree
Oxazolidin-2-one and thiazolidin-2-one derivatives for use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolidin-2-one and thiazolidin-2-one derivatives for use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidin-2-one and thiazolidin-2-one derivatives for use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3594976